Theratechnologies Inc. (TSE:TH – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$4.47 and traded as low as C$4.36. Theratechnologies shares last traded at C$4.47, with a volume of 35,472 shares traded.
Theratechnologies Stock Down 4.9%
The company has a debt-to-equity ratio of -156.22, a quick ratio of 0.64 and a current ratio of 0.84. The stock’s fifty day simple moving average is C$4.47 and its two-hundred day simple moving average is C$4.47. The stock has a market capitalization of C$205.53 million, a P/E ratio of -23.53, a price-to-earnings-growth ratio of -8.50 and a beta of 0.26.
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Recommended Stories
- Five stocks we like better than Theratechnologies
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
